Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Pro...(men and women in 57 countries andsell pr...),Health
Navigation Links
Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
Date:10/16/2007
men and women in 57 countries and sell products throughout the world.
Contacts:
Dave Detmers, 408 942-5955
Laurie Elkin, 212 583-2793
'/>"/>
| SOURCE Johnson & Johnson Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Robert Wood Johnson Foundation Pledges $500M To Fund Anti-Obesity Programs
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
4. Dr Reddy’s Laboratories launches Hyalosy
5. Serum Institute Launches New Tetanus-Diphtheria Vaccine
6. Scottish Health Minister Launches Organ Donor Plan
7. GlaxoSmithKline launches diabetes and cancer drugs
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. Pfizer Launches Viagra For Lung Disease In UK
10. PM Launches Healthcare Foundation For India
11. African Union Launches A Programme On Acceleration of HIV Prevention
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market 2Health News:Centegra Expands H1N1 Vaccines to General Public 2Health News:Centegra Expands H1N1 Vaccines to General Public 3Health News:Centegra Expands H1N1 Vaccines to General Public 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:PeopleStreme Human Capital Releases 'New Trends in Performance Management - 2010' Whitepaper 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4
[0] Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market[0] Centegra Expands H1N1 Vaccines to General Public [0] China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009[1] PeopleStreme Human Capital Releases 'New Trends in Performance Management - 2010' Whitepaper[1] Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For”
Other Medicine News:Health News:Blue Shield of California Names Two New Senior Vice Presidents 2Health News:California Youth Shares Epilepsy Message on Capitol Hill 2Health News:Physical abuse raises women's health costs over 40 percent 2Health News:Illinois Youth Shares Epilepsy Message on Capitol Hill 2Health News:IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark 2Health News:Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen 2
Blue Shield of California Names Two New Senior Vice PresidentsCalifornia Youth Shares Epilepsy Message on Capitol HillPhysical abuse raises women's health costs over 40 percentIllinois Youth Shares Epilepsy Message on Capitol HillIlluminOss(TM) Photodynamic Bone Stabilization System Receives CE MarkClostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 1Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 3Watching stem cells repair the human brain 54909 1Watching stem cells repair the human brain 54909 2Breakthrough uses light to manipulate cell movement 54904 1
[0] RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793)[0] Dynatronics Receives 180-Day NASDAQ Extension[0] Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
Other Medicine Technology:Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine 2
Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney DiseasePositive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |